Abstract
Maralixibat (MRX) is an ileal bile acid transporter inhibitor (IBATi) recently approved by the Food and Drug Administration for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS)...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
